Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (6487)	1/17/2001 10:30:59 PM
From: DaveAu	Respond to of 14101

Mark, We've been talking so much about partners for Pennsaid but I don't ever recall hearing whether Oxo has been in partnership discussions. I assume they must be but I guess a deal isn't likely until phase 3 results are out. I would expect one soon after however given that Oxo will need the cash. Dave

To: Mark Bartlett who wrote (6487)	1/18/2001 12:46:46 AM
From: Montana Wildhack	Respond to of 14101

Mark, Thanks for that article. You are the only one who keeps us informed of this exciting and important aspect of Dimethaid and I always learn from them. PLEASE keep it up. Wolf

To: Mark Bartlett who wrote (6487)	1/18/2001 2:01:04 AM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

Mark, Thanks for the article. A google search shows many hits for Laurie Garrett. "Laurie Garrett, science and health writer, winner of the Pulitzer, Polk, and Peabody Prize, is the author of The Coming Plague and Betrayal of Trust." "Laurie Garrett is the only writer ever to have been awarded all three of the Big "Ps" of journalism: The Peabody, The Polk and The Pulitzer. ... " "Garrett was born in Los Angeles, a 5th generation Los Angeleno. She graduated with honors in biology from the University of California in Santa Cruz. She attended graduate school in the Department of Bacteriology and Immunology at UC Berkeley and did research at Stanford University in the laboratory of Dr. Leonard Herzenberg. During her PhD studies, Garrett started reporting on science news at KPFA, a local radio station. The hobby soon became far more interesting than graduate school and she took a leave of absence to explore journalism. Garrett never completed her PhD." lauriegarrett.com Has she ever written any articles regarding OXO's research??

To: Mark Bartlett who wrote (6487)	1/19/2001 12:24:56 PM
From: Joe Krupa	Read Replies (2) \| Respond to of 14101

Mark, Thanks for posting that very insightful and most important article on HAART. I just had a chance to read it. I get the strong sense that there is a real revolution taking place in the thinking toward HIV. That revolution seems to be developing along two lines: (1) the recognition that anti-retrovirals and HAART are not the answer and often do more harm than good, and (2) the willingness to consider the unorthodox idea that their may be more to AIDS than the HIV virus itself. Certainly the former is developing quicker. WF10 may be arriving at the most opportune of moments. A few years earlier and it may have been buried by the HAART bulls. A few years later, and competition would likely start entering the picture. I think the crest of the wave may be passing by OXO right around the time WF10 is ready for market. I noticed in the article you bolded points you considered important. I will bold one more paragraph that I thought was key: "New research indicates that completely effective HAART would take 70 years to kill off all HIVs in a patient's body. And few patients experience such effectiveness. Most are overcome by drug-resistant forms of the virus." WF10 does does not cause the virus to mutate and thus this concern is eradicated. Thanks again Mark. That was a great read. Joe